Andere Kunden interessierten sich auch für
![Sleep Medicine, an Issue of Medical Clinics of North America]( "Sleep Medicine, an Issue of Medical Clinics of North America")
Sleep Medicine, an Issue of Medical Clinics of North America49,99 €![Psychiatry for the Internist, an Issue of Medical Clinics of North America]( "Psychiatry for the Internist, an Issue of Medical Clinics of North America")
Psychiatry for the Internist, an Issue of Medical Clinics of North America61,99 €![Prediabetes and Diabetes Prevention, An Issue of Medical Clinics of North America]( "Prediabetes and Diabetes Prevention, An Issue of Medical Clinics of North America")
Prediabetes and Diabetes Prevention, An Issue of Medical Clinics of North America52,99 €![Otolaryngology for the Internist, an Issue of Medical Clinics of North America]( "Otolaryngology for the Internist, an Issue of Medical Clinics of North America")
Otolaryngology for the Internist, an Issue of Medical Clinics of North America49,99 €![Urologic issues for the Internist, An Issue of Medical Clinics of North America]( "Urologic issues for the Internist, An Issue of Medical Clinics of North America")
Urologic issues for the Internist, An Issue of Medical Clinics of North America52,99 €![Geriatric Medicine, An Issue of Medical Clinics of North America]( "Geriatric Medicine, An Issue of Medical Clinics of North America")
Geriatric Medicine, An Issue of Medical Clinics of North America52,99 €![Acute Leukemia, An Issue of Hematology/Oncology Clinics of North America]( "Acute Leukemia, An Issue of Hematology/Oncology Clinics of North America")
Acute Leukemia, An Issue of Hematology/Oncology Clinics of North America61,99 €
This issue of Medical Clinics of North America brings the physician up to date on the newest agents for antibacterial therapy. New drugs are covered, as well as new approaches. Topics include the newer fluoroquinolones; epidemiology, molecular mechanisms, and clinical management of pathogens resistant to antibacterial agents; current use for old antibacterial agents, including polymyxins, rifamycins, and aminoglycosides; topical antibacterial agents; newer beta-lactam antibiotics, including doripenem, ceftobiprole. ceftaroline, and cefepim; the use of antibacterial agents in renal failure; antibiotics for gram positive bacterial infections, including vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinolones, daptomycin, telavancin, and ceftaroline; as well as macrolides, ketolides, and glycylcyclines, including azithromycin, clarithromycin, telithromycin, and tigecycline.